2020
DOI: 10.1016/j.parkreldis.2020.02.003
|View full text |Cite
|
Sign up to set email alerts
|

Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 10 publications
0
23
1
Order By: Relevance
“…GAD2 [156], TAC3 [157], NCR1 [158], IL7R [159], GATA3 [160], FCRL3 [161] and IL18R1 [162] have been reported as most promising biomarkers for early diagnosis and prognosis prediction of multiple sclerosis, but these genes might be novel target for AD. FLT3 [163], CHRNB4 [164], PAK1 [165], CHRNB3 [166], GRIN2A [167], CHRNA6 [168], PENK (proenkephalin) [169], CHRNB4 [170], IGF2 [171], TLR9 [172] and CACNG5 [173] were revealed to serve an important role in Parkinson’s disease, but these genes might be novel target for AD. The expression of SLC30A3 [174], NEFH (neurofilament heavy) [175], SYNGR4 [176], S100A4 [177], HSPB1 [178] and KIF5A [179] are associated with amyotrophic lateral sclerosis, but these genes might be novel target for AD.…”
Section: Discussionmentioning
confidence: 99%
“…GAD2 [156], TAC3 [157], NCR1 [158], IL7R [159], GATA3 [160], FCRL3 [161] and IL18R1 [162] have been reported as most promising biomarkers for early diagnosis and prognosis prediction of multiple sclerosis, but these genes might be novel target for AD. FLT3 [163], CHRNB4 [164], PAK1 [165], CHRNB3 [166], GRIN2A [167], CHRNA6 [168], PENK (proenkephalin) [169], CHRNB4 [170], IGF2 [171], TLR9 [172] and CACNG5 [173] were revealed to serve an important role in Parkinson’s disease, but these genes might be novel target for AD. The expression of SLC30A3 [174], NEFH (neurofilament heavy) [175], SYNGR4 [176], S100A4 [177], HSPB1 [178] and KIF5A [179] are associated with amyotrophic lateral sclerosis, but these genes might be novel target for AD.…”
Section: Discussionmentioning
confidence: 99%
“…This mutation was identified as a genetic modifier that enhanced severity of infantile Parkinsonism and is likely to reduce activity of a DN-expressed nAChR. Importantly this mutation was also identified as an enhancer of the disease causing effects of a mutation in WARS2, mitochondrial tryptophanyl tRNA synthase, which was shown to reduce mitochondrial energy production (Martinelli et al, 2020).…”
Section: Involvement Of Protective Mitochondrial-dependent Pathways Imentioning
confidence: 99%
“…Caenorhabditis elegans is a nematode with a defined number of cells (959 somatic cells in the adult), among which 302 are neurons. It has proven to be a useful model organism for investigating molecular and cellular aspects of neuron development and neurodegeneration in numerous human diseases, including PD and other neurodegenerative conditions [91,92]. Moreover, the degeneration of specific neuronal populations, can be easily analyzed in living animals [93], thanks to their transparency and the expression of fluorescent proteins.…”
Section: Role Of Genetically Tractable Models In the Study Of Biologimentioning
confidence: 99%